Nunes Marta C, Madhi Shabir A
Medical Research Council, Respiratory and Meningeal Pathogens Research Unit, University of the Witwatersrand, Johannesburg, South Africa.
Department of Science and Technology/National Research Foundation, Vaccine Preventable Diseases, University of the Witwatersrand, Johannesburg, South Africa.
F1000Res. 2018 Jan 29;7:122. doi: 10.12688/f1000research.12473.1. eCollection 2018.
The influenza virus circulates yearly and causes global epidemics. Influenza infection affects all age groups and causes mild to severe illness, and young infants are at particular risk for serious disease. The most effective measure to prevent influenza disease is vaccination; however, no vaccine is licensed for use in infants younger than 6 months old. Thus, there is a crucial need for other preventive strategies in this high-risk age group. Influenza vaccination during pregnancy protects both the mothers and the young infants against influenza infection. Vaccination during pregnancy boosts the maternal antibodies and increases the transfer of immunoglobulin G from the mother to the fetus through the placenta, which confers protection against infection in infants too young to be vaccinated. Data from clinical trials and observational studies did not demonstrate adverse effects to the mother, the fetus, or the infant after maternal influenza vaccination. We present the current data on the effectiveness and safety of influenza vaccination during pregnancy in preventing disease in the young infant.
流感病毒每年传播并引发全球流行。流感感染影响所有年龄组,可导致从轻症到重症的疾病,而幼儿患重病的风险尤其高。预防流感疾病最有效的措施是接种疫苗;然而,尚无疫苗被批准用于6个月以下的婴儿。因此,在这个高危年龄组中,迫切需要其他预防策略。孕期接种流感疫苗可保护母亲和幼儿免受流感感染。孕期接种疫苗可增强母体抗体,并增加免疫球蛋白G通过胎盘从母亲向胎儿的转移,这可为太小而无法接种疫苗的婴儿提供抗感染保护。临床试验和观察性研究的数据未显示母体接种流感疫苗后对母亲、胎儿或婴儿有不良影响。我们展示了关于孕期接种流感疫苗预防幼儿疾病的有效性和安全性的当前数据。